Building on the O-glycomic landscape of bladder tumours, where GLUT1-positive tumour areas co-localized with ST and STn aberrant glycosylation, a guided downstream glycoprotein annotation by mass spectrometry was employed. Here, SLC2A1 is linked to neoplasm.